PDS Biotechnology's (PDSB) "Overweight" Rating Reaffirmed at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
PDS Biotechnology (NASDAQ:PDSB) Rating Reiterated by B. Riley theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
PDS Biotechnology (NASDAQ:PDSB) Raised to Hold at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) from a sell rating to a hold rating in a research note released on Friday. A number of other research analysts also recently commented on PDSB. Cantor Fitzgerald reiterated an overweight rating on shares of PDS Biotechnology in a report on Friday, January 12th. Oppenheimer […]
PDS Biotechnology (NASDAQ:PDSB – Free Report) had its price objective cut by Oppenheimer from $23.00 to $20.00 in a research report released on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts also recently issued reports on PDSB. B. Riley reaffirmed a buy rating on […]